Antiarrhythmic Drugs 

CLASS I – Sodium Channel Blockers

Drug & Class

Mechanism of Action + Uses

Side Effects + Contraindications

Procainamide (Class IA)

Moderate Na⁺ block + K⁺ block APD & QT. 

Uses: Stable monomorphic VT, pre-excited AF (WPW + AF), SVT with aberrancy

QT prolongation torsades, hypotension (IV), drug-induced lupus, agranulocytosis. 

Avoid in prolonged QT, severe LV dysfunction

Quinidine (Class IA)

Na⁺ + K⁺ block slows conduction, QT. 

Uses: Rare in ICU; AF cardioversion (historical)

Torsades, cinchonism (tinnitus, headache), thrombocytopenia. Avoid in QT prolongation

Disopyramide (Class IA)

Na⁺ block + anticholinergic effect. 

Uses: Hypertrophic obstructive cardiomyopathy (HOCM)

Strong negative inotrope HF worsening, urinary retention, glaucoma, torsades

Lidocaine (Class IB)

Weak Na⁺ block; acts on ischemic ventricular tissue; APD. 

Uses: Ischemic VT, VF (post-MI), refractory VF

CNS toxicity (seizures, confusion), hypotension. Avoid in severe AV block without pacemaker

Mexiletine (Class IB)

Oral lidocaine analogue. 

Uses: Chronic ventricular arrhythmias

GI upset, tremor, CNS toxicity

Flecainide (Class IC)

Strong Na⁺ block marked conduction slowing. 

Uses: Paroxysmal AF (no structural heart disease)

Proarrhythmia, QRS widening, mortality post-MI (CAST trial). Contraindicated in structural heart disease

Propafenone (Class IC)

Na⁺ block + weak β-blockade. 

Uses: Pill-in-pocket AF (selected patients)

Metallic taste, bradycardia, proarrhythmia. Avoid in LV dysfunction



 CLASS II – Beta Blockers

Drug & Class

Mechanism + Uses

Side Effects + Contraindications

Metoprolol (Class II)

Uses: AF with RVR, post-MI arrhythmia, electrical storm

Bradycardia, hypotension, bronchospasm. Avoid in severe asthma, decompensated HF

Esmolol (Class II)

Uses: ICU rate control, peri-intubation tachycardia, electrical storm

Hypotension, bradycardia. Avoid in AV block

Propranolol (Class II)

Uses: Thyroid storm arrhythmias, long QT

Bronchospasm, hypoglycemia masking



 CLASS III – Potassium Channel Blockers

Drug & Class

Mechanism + Uses

Side Effects + Contraindications

Amiodarone (Class III, multi-channel)

Blocks Na, K, Ca + β-block

Uses: Stable VT, VF/pVT (ACLS), AF in structural heart disease, electrical storm

Pulmonary fibrosis, thyroid dysfunction (hypo/hyper), hepatotoxicity, corneal deposits, photosensitivity, bradycardia

Sotalol (Class III + β block)

Uses: AF, VT prevention

High torsades risk, renal dose adjustment required

Dofetilide (Pure Class III)

K⁺ channel block QT. 

Uses: AF maintenance

Torsades, requires inpatient initiation

Ibutilide (Class III)

slow inward Na current APD. 

Uses: Acute AF/flutter cardioversion

High torsades risk give Mg prophylactically



CLASS IV – Calcium Channel Blockers

Drug & Class

Mechanism + Uses

Side Effects + Contraindications

Diltiazem (Class IV)

L-type Ca block AV conduction. 

Uses: AF with RVR (stable)

Hypotension, bradycardia. Avoid in HFrEF, WPW + AF

Verapamil (Class IV)

Uses: SVT, AF rate control

Severe hypotension, heart block. Avoid in LV dysfunction



OTHER IMPORTANT ICU ANTIARRHYTHMICS

Drug

Mechanism + Uses

Side Effects + Contraindications

Adenosine

Transient AV nodal block. 

Uses: PSVT, diagnostic for narrow complex tachycardia

Flushing, chest pain, transient asystole. Avoid in asthma, irregular wide complex tachycardia

Magnesium sulfate

Stabilizes myocardium; suppresses early afterdepolarizations. 

Uses: Torsades de pointes, long QT

Flushing, hypotension in rapid infusion

Digoxin

Vagal tone AV conduction. 

Uses: AF in HFrEF, hypotensive AF

Toxicity: arrhythmias, visual changes, hyperkalemia. Avoid in WPW + AF



CRITICAL ICU CONTRAINDICATION TABLE

Situation

Absolutely Avoid

WPW + AF

Beta blocker, Diltiazem, Verapamil, Digoxin, Adenosine

Structural heart disease

Class IC drugs

Long QT

Class IA, Class III

Decompensated HFrEF

Verapamil, Diltiazem


 Drug of Choice Table 

VENTRICULAR TACHYCARDIA (VT)

1. Monomorphic VT (Regular Wide Complex)

Scenario

Drug of Choice

Stable monomorphic VT (structural heart disease)

Amiodarone

Stable monomorphic VT (no severe LV dysfunction)

Procainamide (often superior efficacy)

Ischemic VT (post-MI)

Lidocaine

Recurrent VT

Amiodarone infusion ± Beta blocker

Scar-related VT

Amiodarone


2. Polymorphic VT (Normal QT)

Scenario

Drug of Choice

Stable polymorphic VT (normal QT)

Amiodarone


3. Torsades de Pointes (Polymorphic VT with Long QT)

Scenario

Drug of Choice

Torsades (any Mg level)

Magnesium sulfate IV (2 g)

Bradycardia-induced torsades

Isoproterenol or temporary pacing

Drug-induced QT prolongation

Stop offending drug + Mg


4. Electrical Storm

(≥3 VT/VF episodes in 24 hrs)

Scenario

Drug of Choice

Electrical storm (structural heart disease)

Amiodarone + Beta blocker (Esmolol/Metoprolol)

Refractory

Add Lidocaine

Ischemic trigger

Urgent revascularization

Sympathetic surge

Deep sedation ± Stellate ganglion block


 SUPRAVENTRICULAR TACHYCARDIA (SVT)

1. AVNRT (Most Common SVT)

Scenario

Drug of Choice

Stable AVNRT

Adenosine

If adenosine contraindicated

Diltiazem or Verapamil

Recurrent

Beta blocker


2. AVRT (WPW Syndrome)

Orthodromic AVRT (Narrow Complex)

Scenario

Drug of Choice

Stable

Adenosine

Recurrent

Beta blocker

3.Antidromic AVRT (Wide Complex)

Scenario

Drug of Choice

Stable

Procainamide

Avoid

AV nodal blockers


4. Atrial Fibrillation (AF)

Scenario

Drug of Choice

AF with RVR (stable, no HFrEF)

Diltiazem or Beta blocker

AF with RVR + HFrEF

Amiodarone or Digoxin

AF < 48 hrs (rhythm control)

Amiodarone

AF > 48 hrs

Rate control + anticoagulation

AF + WPW (pre-excited AF)

Procainamide


5. Atrial Flutter

Scenario

Drug of Choice

Stable rate control

Diltiazem / Beta blocker

Rhythm conversion

Ibutilide or Amiodarone


6. Multifocal Atrial Tachycardia (MAT)

Scenario

Drug of Choice

MAT (COPD patient)

Treat underlying + Magnesium

Rate control

Verapamil